All Episodes
00:12:05
Graphene Manufacturing CEO on fuel savings & expansion
Proactive - Interviews for investors
·
2025/03/17
en
00:04:37
Arrow Exploration reports 2024 reserves growth,...
Proactive - Interviews for investors
·
2025/03/14
en
00:04:03
Falcon Gold unveils high-resolution drill core images...
Proactive - Interviews for investors
·
2025/03/14
en
00:04:20
Tonix Pharmaceuticals secures MCDC grant to advance...
Proactive - Interviews for investors
·
2025/03/14
en
00:07:07
Mag Mile Capital accelerates growth with $80M in...
Proactive - Interviews for investors
·
2025/03/14
en
00:07:10
Atlantic Lithium chairman Neil Herbert on Ewoyaa's...
Proactive - Interviews for investors
·
2025/03/14
en
00:07:48
Digitalbox expands with potential acquisition of The...
Proactive - Interviews for investors
·
2025/03/14
en
00:07:57
Surefire Resources secures critical minerals offtake...
Proactive - Interviews for investors
·
2025/03/14
en
00:08:36
00:08:55
PT Asset Management CEO Sean Dranfield on 'shape...
Proactive - Interviews for investors
·
2025/03/14
en
00:04:43
Element 25’s Butcherbird expansion: what’s next?
Proactive - Interviews for investors
·
2025/03/14
en
00:05:22
Aguia Resources’ path to cash flow & expansion as it...
Proactive - Interviews for investors
·
2025/03/14
en
00:03:31
Charbone Hydrogen partners with ABB to develop 15...
Proactive - Interviews for investors
·
2025/03/13
en
00:05:25
Standard Uranium identifies high-priority targets at...
Proactive - Interviews for investors
·
2025/03/13
en
00:03:00
Delivra Health expands Dream Water line with 6-count...
Proactive - Interviews for investors
·
2025/03/12
en
00:07:35
Pantera Lithium: drilling plans in Smackover hotspot...
Proactive - Interviews for investors
·
2025/03/12
en
00:05:37
Quantum Blockchain update reveals good progress...
Proactive - Interviews for investors
·
2025/03/12
en
00:05:28
GoviEx Uranium CEO on Muntanga feasibility study...
Proactive - Interviews for investors
·
2025/03/12
en
00:06:10
Provaris Energy in 'sweet spot' with second MOU for...
Proactive - Interviews for investors
·
2025/03/12
en
00:07:05
Immunic Therapeutics advances MS Drug , Phase 2...
Proactive - Interviews for investors
·
2025/03/12
en